Abstract:OBJECTIVE:To investigate the feasibility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in differentiating musculoskeletal tumors with different behaviours of pathological findings before therapy. METHODS:A total of 34 subjects of musculoskeletal tumors were involved in this retrospective analysis. DCE-MRI was performed using a fat-saturated 3D VIBE (volumetric interpolated breath-hold exam) imaging sequence with following parameters: FA, 10 degree; TR/TE, 5.6/2.4 ms; slice thickness, 4.0 mm with no intersection gap; field of view, 310 mm×213 mm; matrix, 256×178; voxel size, 1.2 mm×1.2 mm×4.0 mm; parallel imaging acceleration factor. The actuation time for the DCE-MRI sequence was 255 s with a temporal resolution of 5 s and 40 image volumes. Using pathological results as a gold standard, tumors were divided into benign, borderline and malignant tumors. Toft's model was used for calculation of K(trans) (volume transfer constant), Ve (extravascular extracellular space distribute volume per unit tissue volume) and Kep (microvascular permeability reflux constant). Those parameters were compared between the lesions and the control tissues using paired t tests. The one-way analysis of variance was used to assess the difference among benign, borderline and malignant tumors. P values <0.05 difference was statistically significant. RESULTS:Based on the WHO Classification of Tumours of Soft Tissue and Bone(2012) criteria, 34 patients were divided into three groups: 11 for benign tumors, 12 for borderline tumors, and 11 for malignancies. Compared with control tissues, K(trans) and Kep showed no difference, but Ve was increased in benign tumors, Kep showed no difference, but K(trans) and Ve were increased in borderline tumors,K(trans), Kep and Ve were increased in malignant tumors. K(trans) (P<0.001) and Kep (P<0.01) were significantly higher in malignant tumors than in benign and borderline tumors, but did not show any difference between benign tumors and borderline tumors. Ve was significantly higher in malignant tumors than in benign (P<0.05), but did not show any difference between malignant and borderline tumors, benign tumors and borderline tumors (P>0.05). CONCLUSION:DCE-MRI technique is useful to evaluate the pathological behaviour of musculoskeletal tumors. The quantitative analysis of DCE parameters in conjunction with conventional MR images can improve the accuracy of musculoskeletal tumor qualitative analysis.

Study of DCE MRI and ~1H-MRS of giant cell tumor of bone

Imaging Features, Staging System, and Surgical Management of Giant Cell Lesions of the Temporal Bone.

Imaging Findings of Giant Cell Tumor of Tendon Sheath

Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.

MRI Appearances of Giant Cell Tumors in the Mobile Spine:Compared with Pathology

The Analysis of Common MRI Signs and Typical Cases of Bone Gant Cell Tumor

Giant Cell Tumor of the Tendon Sheath: Magnetic Resonance Imaging Findings in 38 Patients.

CT and MRI Features of Extraocular Muscle Granular Cell Tumour: Preliminary Experience in Eight Cases

Giant cell tumor of bone of temporal bone and skull base: report of 6 cases

Multimodality imaging of an unusual giant cell tumor of thoracic spine with mediastinal invasion: a case report

Multimodal imaging in the diagnosis of bone giant cell tumors: A retrospective study

Comparison of Diagnostic Value of X Ray,ct and MRI Imaging in the Diagnosis of Giant Cell Tumor of Bone

The Primary Evaluation MRI in Diagnosis of Giant Cell Tumor of Bone

Study of Single Voxel 1H MR Spectroscopy of Bone Tumors: Differentiation of Benign from Malignant Tumors.

SigniifcanceofquantitativeanalysisofenhancedCTscaninthequalitativediagnosisofthegiantcelltumorof ;the bone

Tumor Infiltration of Bone Marrow in Patients with Hemato-Logical Malignancies: Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Spinal Giant Cell Tumor:Imaging Features and Its Clinical Value

[Feasibility Study of Dynamic Contrast Enhanced Magnetic Resonance Imaging Qualitative Diagnosis of Musculoskeletal Tumors].

The CT Manifestations of Giant Cell Tumor of Bone

Signs of Tumor Infiltration of Bone Marrow in Patients with Hematological Malignancies on Dynamic Contrast-Enhanced MR Imaging: Preliminary Results

Giant Cell Tumour of the Tendon Sheath of the Spine: Clinical Features and Imaging Findings